Trials / Completed
CompletedNCT04667442
Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects
An Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 137 (actual)
- Sponsor
- Nanomix · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Prospective samples will be collected to evaluate the agreement between a EUA RT-PCR test as the comparator method against the Nanomix eLab® system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional) | COVID-19 Rapid Antigen Diagnostic Test |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-12-14
- Completion
- 2021-12-14
- First posted
- 2020-12-14
- Last updated
- 2021-12-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04667442. Inclusion in this directory is not an endorsement.